REVIEW 1 cited by
Neural Stain Normalization and Unsupervised Classification of Cell Nuclei in Histopathological Breast Cancer Images
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
In this paper, we develop a complete pipeline for stain normalization, segmentation, and classification of nuclei in hematoxylin and eosin (H&E) stained breast cancer histopathology images. In the first step, we use a CNN-based stain transfer technique to normalize the staining characteristics of (H&E) images. We then train a neural network to segment images of nuclei from the H&E images. Finally, we train an Information Maximizing Generative Adversarial Network (InfoGAN) to learn visual representations of different types of nuclei and classify them in an entirely unsupervised manner. The results show that our proposed CNN stain normalization yields improved visual similarity and cell segmentation performance compared to the conventional SVD-based stain normalization method. In the final step of our pipeline, we demonstrate the ability to perform fully unsupervised clustering of various breast histopathology cell types based on morphological and color attributes. In addition, we quantitatively evaluate our neural network - based techniques against various quantitative metrics to validate the effectiveness of our pipeline.
Forward citations
Cited by 1 Pith paper
-
MorphGen: Morphology-Guided Representation Learning for Robust Single-Domain Generalization in Histopathological Cancer Classification
MorphGen uses supervised contrastive learning to align histopathology images with nuclear masks and applies SWA, reporting improved out-of-domain cancer classification accuracy on CAMELYON17, BCSS, and OCELOT.
Discussion (0). Continue with ORCID to comment.